Triple
T15982936
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Ariad Pharmaceuticals |
E387618
|
entity |
| Predicate | ponatinibBrandName |
P65955
|
FINISHED |
| Object |
Iclusig
Iclusig is a cancer medication containing ponatinib, primarily used to treat certain types of leukemia such as chronic myeloid leukemia (CML) and Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL).
|
E1188112
|
NE FINISHED |
Provenance (6 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69d86da94ccc819083d187f5dc6a123e |
elicitation | completed |
| NER | batch_69e17d4d08f481909f38b75e3f42d9ab |
ner | completed |
| NED1 | batch_69ffc3cdf7848190848e9081027dc027 |
ned_source_triple | completed |
| NED2 | batch_69ffc5c7db1c8190b4e1de6f6e3ce8a0 |
ned_description | completed |
| NEDg | batch_69ffc5669c1c81909bacf61c96cb7816 |
nedg | completed |
| PD | batch_69e142d9d8e881909b559a3e3ca21d24 |
pd | completed |
Created at: April 10, 2026, 4:54 a.m.